The Challenge
The entrepreneur that created Symbiomix needed to raise capital to realize his vision.
This required the preparation of all needed marketing material needed to go to market and identifying investors willing to invest in a differentiated infectious disease compound.
The Solution
KYBORA analyzed the situation, prepared all the marketing material including teaser, non-conf, confidential info memo, and a virtual data room, performed a valuation to help with future funding negotiations, identified about 120 potential investors and systematically reached out to them to gauge their level of interest. Once a lead was identified, KYBORA worked with the founder to help identify co investors to form a syndicate.
The Outcome
Symbiomix raised $35M from Orbimed and F-Prime and used those proceeds to successfully receive an FDA approval in 2017.
To download the Symbiomix success story, please click here.